Our CEO/CSO Luigi Aurisicchio has been interviewd at Radio Cusano Campus, on the programme “Genetica oggi”. He summarized Takis research in the field of oncology and rare diseases.
Our company uses innovative and personalized technology to harness the immune system and increase life expectancy of patients. We made it possible thanks to a young and multidisciplinary team of scientists, with industrial and pharmaceutical backgrounds, able to develop drugs and transform basic research into real life.
We were delighted to make the public aware of our story and mission. Research in Italy has been having a hard time. Still, there are institutions like ours that do high level research with passion and commitment.
Listen to the interview (in Italian): https://www.tag24.it/podcast/luigi-aurisicchio-nuovi-farmaci-e-vaccini-antitumorali/